Johannes Thrul1, Maya Vijayaraghavan2, Sara Kalkhoran3, Jason M Satterfield4. 1. Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, United States of America. Electronic address: jthrul@jhu.edu. 2. Division of General Internal Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, United States of America. 3. Division of General Internal Medicine, Massachusetts General Hospital and Harvard Medical School, United States of America. 4. Division of General Internal Medicine, University of California, San Francisco, United States of America.
Abstract
BACKGROUND: Poly-use of tobacco, cannabis, and electronic cigarettes (e-cigarettes) is an emerging problem in the general population. The current study investigated poly-use of these products and receipt of smoking cessation counseling in a primary care setting. METHODS: We conducted a cross-sectional secondary data analysis from a trial of a tablet intervention to increase provider delivery of the 5As (Ask, Advise, Assess, Assist, Arrange follow-up), a brief counseling intervention for smoking cessation, in 3 diverse primary care clinics in San Francisco, CA from 2014 to 2015. Participants were currently smoking cigarettes (N = 601; mean age = 50.8; 38.1% female) and reported information on past 30-day cigarette and e-cigarette use and past 3-month cannabis use. We classified participants into 4 groups: (1) cigarette-only, (2) dual-use of cigarettes and e-cigarettes, (3) dual-use of cigarettes and cannabis, (4) poly-use of cigarettes, e-cigarettes, and cannabis, and examined correlates of use. RESULTS: Only cigarette smoking was reported by 48.6% of participants, 30.4% reported use of cigarettes and cannabis, 10.5% reported use of cigarettes and e-cigarettes, and 10.5% reported use of cigarettes, e-cigarettes, and cannabis. Cigarette-only smokers did not differ from other groups by cigarette smoking behavior and motivation to quit. Patients reporting dual-use of cigarettes and e-cigarettes had a higher likelihood of receiving the Arrange step and all 5As compared to cigarette-only smokers. CONCLUSIONS: Providers should screen for co-use of cigarettes and other nicotine/cannabis products and consider co-use when delivering smoking cessation treatment and evaluating treatment outcomes. Development of guidelines to help facilitate provider training is needed.
BACKGROUND:Poly-use of tobacco, cannabis, and electronic cigarettes (e-cigarettes) is an emerging problem in the general population. The current study investigated poly-use of these products and receipt of smoking cessation counseling in a primary care setting. METHODS: We conducted a cross-sectional secondary data analysis from a trial of a tablet intervention to increase provider delivery of the 5As (Ask, Advise, Assess, Assist, Arrange follow-up), a brief counseling intervention for smoking cessation, in 3 diverse primary care clinics in San Francisco, CA from 2014 to 2015. Participants were currently smoking cigarettes (N = 601; mean age = 50.8; 38.1% female) and reported information on past 30-day cigarette and e-cigarette use and past 3-month cannabis use. We classified participants into 4 groups: (1) cigarette-only, (2) dual-use of cigarettes and e-cigarettes, (3) dual-use of cigarettes and cannabis, (4) poly-use of cigarettes, e-cigarettes, and cannabis, and examined correlates of use. RESULTS: Only cigarette smoking was reported by 48.6% of participants, 30.4% reported use of cigarettes and cannabis, 10.5% reported use of cigarettes and e-cigarettes, and 10.5% reported use of cigarettes, e-cigarettes, and cannabis. Cigarette-only smokers did not differ from other groups by cigarette smoking behavior and motivation to quit. Patients reporting dual-use of cigarettes and e-cigarettes had a higher likelihood of receiving the Arrange step and all 5As compared to cigarette-only smokers. CONCLUSIONS: Providers should screen for co-use of cigarettes and other nicotine/cannabis products and consider co-use when delivering smoking cessation treatment and evaluating treatment outcomes. Development of guidelines to help facilitate provider training is needed.
Authors: Sara Kalkhoran; Nicole A Appelle; Anna M Napoles; Ricardo F Munoz; Paula J Lum; Nicholas Alvarado; Steven E Gregorich; Jason M Satterfield Journal: J Subst Abuse Treat Date: 2015-06-06
Authors: Andrew S Nickels; David O Warner; Sarah Michelle Jenkins; Jon Tilburt; J Taylor Hays Journal: Nicotine Tob Res Date: 2016-08-24 Impact factor: 4.244
Authors: Jamie L Studts; Sameer R Ghate; Jaime L Gill; Christina R Studts; Christopher N Barnes; A Scott LaJoie; Michael A Andrykowski; Renato V LaRocca Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-10 Impact factor: 4.254
Authors: Hanan Qasim; Zubair A Karim; Jose O Rivera; Fadi T Khasawneh; Fatima Z Alshbool Journal: J Am Heart Assoc Date: 2017-08-30 Impact factor: 5.501
Authors: Natacha M De Genna; Lidush Goldschmidt; Gale A Richardson; Marie D Cornelius; Nancy L Day Journal: Addict Behav Date: 2021-01-09 Impact factor: 3.913